CARVALHO Agostinho's profile
avatar

CARVALHO Agostinho

  • Life and Health Sciences Research Institute (ICVS) - School of Medicine, University of Minho, Braga, Portugal
  • Biochemistry of infections, Cell biology of hosts, infectious agents, or vectors, Diagnosis, Genomics, functional genomics of hosts, infectious agents, or vectors, Immunity to infections (innate, adaptive), Immunogenomics, Interactions between hosts and infectious agents/vectors, Microbiology of infections, Pathogenic/Symbiotic Fungi, Physiology of hosts, infectious agents, or vectors, Population genetics of hosts, infectious agents, or vectors
  • recommender

Recommendations:  0

Reviews:  0

Educational and work
Agostinho Carvalho graduated in 2003 in Biology from the University of Minho and received a PhD in Health Sciences from the same University in 2008. Between 2009 and 2012, he developed postdoctoral studies on the genetic basis of susceptibility to fungal infection at the Life and Health Sciences Research Institute (ICVS) of the University of Minho, and the University of Perugia, Italy. In 2012, he became an Assistant Researcher at the Department of Experimental Medicine of the University of Perugia, where he further developed his interests in fungal immunology and immunogenetics until 2014. Later that year, he became an Assistant Researcher (FCT Investigator) and returned to ICVS, where he consolidated his research team. Since 2019, he is a Principal Investigator at ICVS (tenured since 2021). His research activity is focused on the elucidation of the effects of interindividual genetic variation on molecular and cellular processes of immunity and inflammation, and the translation of this information into new and personalized approaches for the prognosis, diagnosis, and therapy of infectious and inflammatory diseases. These aims are being addressed by a multidisciplinary team that combines basic scientists and clinical experts with different degrees of specialization, and that resorts to advanced cellular and animal models of disease and human patients enrolled in national and international consortia. The team is also engaged in collaborations with several international labs on immunology, functional genomics, and biology of infectious and inflammatory diseases.
avatar

CARVALHO Agostinho

  • Life and Health Sciences Research Institute (ICVS) - School of Medicine, University of Minho, Braga, Portugal
  • Biochemistry of infections, Cell biology of hosts, infectious agents, or vectors, Diagnosis, Genomics, functional genomics of hosts, infectious agents, or vectors, Immunity to infections (innate, adaptive), Immunogenomics, Interactions between hosts and infectious agents/vectors, Microbiology of infections, Pathogenic/Symbiotic Fungi, Physiology of hosts, infectious agents, or vectors, Population genetics of hosts, infectious agents, or vectors
  • recommender

Recommendations:  0

Reviews:  0

Educational and work
Agostinho Carvalho graduated in 2003 in Biology from the University of Minho and received a PhD in Health Sciences from the same University in 2008. Between 2009 and 2012, he developed postdoctoral studies on the genetic basis of susceptibility to fungal infection at the Life and Health Sciences Research Institute (ICVS) of the University of Minho, and the University of Perugia, Italy. In 2012, he became an Assistant Researcher at the Department of Experimental Medicine of the University of Perugia, where he further developed his interests in fungal immunology and immunogenetics until 2014. Later that year, he became an Assistant Researcher (FCT Investigator) and returned to ICVS, where he consolidated his research team. Since 2019, he is a Principal Investigator at ICVS (tenured since 2021). His research activity is focused on the elucidation of the effects of interindividual genetic variation on molecular and cellular processes of immunity and inflammation, and the translation of this information into new and personalized approaches for the prognosis, diagnosis, and therapy of infectious and inflammatory diseases. These aims are being addressed by a multidisciplinary team that combines basic scientists and clinical experts with different degrees of specialization, and that resorts to advanced cellular and animal models of disease and human patients enrolled in national and international consortia. The team is also engaged in collaborations with several international labs on immunology, functional genomics, and biology of infectious and inflammatory diseases.